Cardiac Resynchronization Therapy

Cardiac Pacing and ICDs, Fourth Edition

Volumn , Issue , 2007, Pages 415-466

  Sweeney, Michael O ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atrioventricular optimization; Intraventricular; Modulation; Therapy; Thrombosis

Indexed keywords

EID: 79952042529     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470750674.ch9     Document Type: Chapter

References (93)

1. Schocken DD,Arrieta MI, leaverton PE, Ross EA. Prevalence and mortality of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-306.
2. Ho KKL, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in the Framingham Heart Study subjects. Circulation 1993;88:107-115.
3. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure. Am Heart J 1997;133:703-712.
4. Kannel WB, Plehn JF, Cupples A. Cardiac failure and sudden death in the Framingham study. Am Heart J 1988;115:869-875.
5. Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art. Cost versus benefit. Circulation 2004;109:300-307.
6. Leclerc C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002;39:194-201.
7. Wiggers C.The muscular reactions of the mammalian ventricles to artificial surface stimuli. Am J Physiol 1925;73:346-378.
8. Schlant RC. Idioventricular kick. Circulation 1966;33 (Suppl III):III-209.
9. Gottipaty VK, Krelis SP, Lu F, et al. The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis in patients with chronic congestive heart failure. J Am Coll Cardiol 1999;33:145A. Abstract.
10. Baldasseroni S, Opasich C, Gorinii M, et al. Left bundle branch block is associated with increased 1-year sudden death and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart Failure. Am Heart J 2002;143:398-405.
11. Grines CL, Boshore TW, Boudoulas H, et al. Functional abnormalities in isolated left bundle branch block: the effect of interventricular asynchrony. Circulation 1989;79:845-853.
12. Leclerq C, Faris O, Runin R, et al. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 2002;106:1760-1763.
13. Verbeek XA,Vernooy K, Peschar M. Intra-ventricular resynchronization for optimal left ventricular function during pacing in experimental left bundle branch block. J Am Coll Cardiol 2003;42:558-567.
14. Prinzen FW, Hunter WC,Wyman BT, et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999;33:1735-1742.
15. Prinzen FW, Augustijn CH, Arts T, Allessi MA, Reneman RS. Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol 1990(259):H300-308.
16. Spragg DD, Leclercq C, Loghmani M, et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 2003;108:929-932.
17. Prinzen FW, Cheriex EC, Delhaas T, et al. Asymmetric thickness of the left ventricular wall resulting from asynchronous electric activation: a study in dogs with ventricular pacing and in patients with left bundle branch block. Am Heart J 1995;130:1045-1053.
18. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;203:765-770.
19. Auricchio A, Fantoni C, Regoli F, et al. Characterization of left ventricular activation in patients with heart failure and left bundle branch block. Circulation (in press).
20. de Teresa E, Chamorro JL, Pulpon LA, et al. An even more physiologic pacing. Changing the sequence of activation. In: Steinbech K GD, Laskovics A, et al., eds. Cardiac Pacing. Proceedings of the VIIth World Symposium on Cardiac Pacing, 1984. Darmstadt, Germany: Steinkoopff Verlag; 1984:395-400.
21. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994;17:1974-1979.
22. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999;99(23):2993-3001.
23. Nelson GS, Curry CW,Wyman BT, et al. Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 2000;101(23):2703-2709.
24. Kerwin WF, Botvinick EH, O'Connell JW, et al.Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000;35:1221-1227.
25. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle branch block. Circulation 2000;105:3053-3059.
26. St John Sutton MG, Plappert T,Abraham WT, et al, for the MIRACLE Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;105(1985-1990).
27. Sogaard P, Egeblad H, Pedersen AK, et al. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation 2002;106:2078-2084.
28. Lau CP, Yu CM, Chau E, et al. Reversal of left ventricular remodeling by synchronous biventricular pacing in heart failure. Pacing Clin Electrophysiol 2000;23: 1722-1725.
29. Van Oosterhout MFM, Prinzen FW, Arts T, et al. Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation 1998;98: 588-595.
30. Cannan CR, Higano ST, Holmes DR. Pacemaker induced mitral regurgitation: an alternative form of pacemaker syndrome. Pacing Clin Electrophysiol 1997;20: 735-738.
31. Nunez A, Alberga MT, Cosio FG, et al. Severe mitral regurgitation with right ventricular pacing successfully treated with left ventricular pacing. Pacing Clin Electrophysiol 2002;25:226-230.
32. Garrigue S, Jais P, Espil G, et al. Comparison of chronic biventricular pacing between epicardial and endocardial left ventricular stimulation using Doppler tissue imaging in patients with heart failure. Am J Cardiol 2001;88(8):858-862.
33. Jais P,Takahashi A, Garrigue S, et al. Mid-term follow-up of endocardial biventricular pacing. Pacing Clin Electrophysiol 2000;23:1744-1747.
34. Daubert CJ, Ritter P, LeBreton H, et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 1998;21:239-345.
35. Meisel E, Pfeiffer D, Engelmann L, et al. Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation 2001;104:442-447.
36. Auricchio A, Stellbrink C, Sack S, et al.The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999;83(5B):130D-135D.
37. Auricchio A, Klein H,Tockman B, et al.Transvenous biventricular pacing for heart failure: can the obstacles be overcome? American Journal of Cardiology 1999;83(5B): 136D-142D.
38. Butter C, Auricchio A, Stellbrink C, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001; 104(25):3026-3029.
39. Fauchier L, Marie O, Casset-Senon D, et al. Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with fourier phase analysis of radionuclide angioscintigraphy. J Am Coll Cardiol 2002;40(11): 2031-2033.
40. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39(12):2026-2033.
41. Garrigue S, Jais P, Espil G, et al. Comparison of chronic biventricular pacing between epicardial and endocardial left ventricular stimulation using doppler tissue imaging in patients with heart failure. Am J Cardiol 2001;88:858-862.
42. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346(24):1845-1853.
43. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-2694.
44. Bristow MR, Feldman AM, Saxon LA, et al. COMPANION. In: Heart Failure Society of America, Late Breaking Clinical Trial Presentation; 2003.
45. Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997;96:3273-3277.
46. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99(12):1567-1573.
47. Touiza A, Etienne Y, Gilard M, et al. Long-term left ventricular pacing: assessment and comparison with biventricular pacing in patients with severe congestive heart failure. J Am Coll Cardiol 2001;38:1966-1970.
48. Blanc JJ, Bertault-Valls V, Fatemi M, et al. Long-term benefits of left univentricular pacing in patients with congestive heart failure. Circulation 2004; In press.
49. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1993-1940.
50. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877-883.
51. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death among patients with coronary artery disease.N Engl J Med 1999;341:1882-1890.
52. Bardy GH. The Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). In: Late-Breaking Clinical Trials, American College of Cardiology; 2004.
53. Butter C, Meisel E, Engelmann L, et al. Human experience with transvenous biventricular defibrillation using an electrode in a left ventricular vein. Pacing and Clin Electrophysiol 2002;25(3):324-331.
54. Auricchio A, Kramer A, Spinelli J, et al. Can the optimum dosage of resynchronization therapy be derived from the intracardiac electrogram? J Am Coll Cardiol 2002;39:124. Abstract.
55. Reuter R, Garrigue S, Barold SS, et al. Comparisons of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002;89:346-350.
56. Bax JJ, Mohoek SG, Marwick TJ, et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 2003;92:1238-1240.
57. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615-1622.
58. Kerckhoffs RC, Bovendeerd PH, Kotte JC, et al. Homogeneity of cardiac contraction despite physiological asynchrony of depolarization: a model study. Ann Biomed Eng 2003;31:536-547.
59. Kadhiresan V,Vogt J, Auricchio A, et al. Sensitivity and specificity of QRS duration to predict acute benefit in heart failure patients with cardiac resynchronization. Pacing Clin Electrophysiol 2000;23(II):555. Abstract.
60. D'Hooge J, Heimdal A, Jamal F, et al. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiography 2000;1:154-170.
61. Breithardt OA, Stellbrink C, Herbots L, et al. Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block. J Am Coll Cardiol 2003;42:486-494.
62. Sogaard P, Egeblad H, Kim W, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:723-730.
63. Baxx JJ, Yu C-M, Lin H, et al. Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular pacing and right ventricular pacing for congestive heart failure. Am Heart J 2003;145:G1-G7.
64. Bax JJ, Molhoek SG, Marwick TH, et al. Usefulness of myocardial tissue Doppler echocardiography to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2003;91:94-97.
65. Yu C-M, Fung W-H, Lin H, et al. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2002;91:684-688.
66. Auricchio A, Stellbrink C, Sack S, et al. Long-term benefit as a result of pacing resynchronization in congestive heart failure: results of the PATH-CHF Trial. Circulation 2000;102:II-693A.
67. Linde C, Leclerc C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: Results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002;40:111-118.
68. Linde C, Braunschweig F, Gadler F, Bailleul C, Daubert JC. Long-term improvement in quality of life by biventricular pacing in patients with chronic heart failure: results from the MUSTIC Study. Am J Cardiol 2003;91:1090-1095.
69. Aranda JM, Curtis AB, Conti JB, Stejskal-Peterson S. Do heart failure patients with right bundle branch block benefit from cardiac resynchronization therapy? Analysis of the MIRACLE Study. J Am Coll Cardiol 2002;39:96A. Abstract.
70. Yu C-M,Yang H, Lau C-P, et al. Regional left ventricular mechanical asynchrony in patients with heart disease and normal QRS duration. Pacing Clin Electrophysiol 2003;26:562-570.
71. Achilli A, Sassara M, Ficili S, et al. Long term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS duration. J Am Coll Cardiol 2003;42:2117-2124.
72. Kass DM. Predicting cardiac resynchronization response by QRS duration. J Am Coll Cardiol 2003;42:2125-2127.
73. Gaspirini M, Mantica M, Galimberti P, et al. Beneficial effects of biventricular pacing in patients with a "narrow" QRS duration. Pacing Clin Electrophysiol 2003; 26:169-174.
74. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;23:2932-2937.
75. The DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288(24):3115-3123.
76. Peschar M, de Swart H, Michels KJ, Reneman RS, Prinzen FW. Left ventricular septal and apex pacing for optimal pump function in canine hearts. J Am Coll Cardiol 2003;41(7):1218-1226.
77. Cazeau S, Leclerlq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
78. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289:730-740.
79. Gillum RF. Sudden coronary death in the United States. Circulation 1989;79: 756-765.
80. Moss AJ. Sudden cardiac death and national health. Pacing Clin Electrophysiol 1993;16:2190-2191.
81. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337: 1576-1583.
82. Kuck KH, Cappato R, Siebels J, Ruppel F, for the CASH Investigators. Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754.
83. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
84. Shamim W, Francis DP,Yousufuddin M, et al. Intra-ventricular conduction delay: a prognostic marker in congestive heart failure. Int J Cardiol 1999;70:171-178.
85. Gerber TC, Nishimura R, Holmes DR, et al. Left ventricular and biventricular pacing in congestive heart failure. Mayo Clin Proc 2001;706:803-812.
86. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure and intraventricular conduction delay and malignant ventricular tachyarrhythmia. J Am Coll Cardiol 2003;42:1454-1459.
87. Moss AJ. Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. Circulation 2000;101:1638-1640.
88. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-2007.
89. Uretsky B, Sheahan G. Primary prevention of sudden cardiac death in heart failure: will the result be shocking? J Am Coll Cardiol 1997;30:1589-1597.
90. Luu M, Stevenson WG, Saxon LA, Stevenson LW. Diverse mechanisms of unexpected cardiac arrest in heart failure. Circulation 1989;80:1675-1680.
91. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: importance of post-shock electromechanical dissociation. J Am Coll Cardiol 2002;39(8):1323-1328.
92. Mohri S, He KL, Dickstein M, et al. Cardiac contractility modulation by electrical currents applied during the refractory period. Am J Physiol Heart Circ Physiol 2002;282:H1642-H1647.
93. Pappone C,Augello G, Rosanio S, et al. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol 2004;15:418-427.